<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26803" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pediatric Malignant Pleural Effusion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adeyinka</surname>
            <given-names>Adebayo</given-names>
          </name>
          <aff>The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kondamudi</surname>
            <given-names>Noah P.</given-names>
          </name>
          <aff>Icahn School of Medicine at Mount Sinai , The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adebayo Adeyinka declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noah Kondamudi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26803.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The pleural cavity is a sac lined with a serous membrane that encloses the lungs and separates them from the thoracic cage. An inner layer covers the surface of the lungs called the visceral pleura. The outer layer is the parietal pleural. A minuscule amount of fluid that is approximately 10 microliters thick can be found between the 2 layers. The amount of fluid in the pleural cavity is regulated by a fine balance in the oncotic and hydrostatic pressures between the pleural space and the intravascular components coupled with the perilymphatic drainage. The Frank-Starling law controls this process. This activity reviews the causes, pathophysiology, and presentation of pediatric malignant pleural effusions and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of pediatric malignant pleural effusions.</p></list-item><list-item><p>Describe the history and physical exam findings that are commonly seen in pediatric malignant pleural effusions.</p></list-item><list-item><p>Outline the treatment options available for pediatric malignant pleural effusions.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication and improving outcomes for pediatric malignant pleural effusions.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26803&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26803">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26803.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The pleural cavity is a thin layer of the sac that is lined with a serous membrane that encloses the lungs and separates them from the thoracic cage. An inner layer covers the surface of the lungs called the visceral pleura. The outer layer is the parietal pleural.<xref ref-type="bibr" rid="article-26803.r1">[1]</xref><xref ref-type="bibr" rid="article-26803.r2">[2]</xref>A minuscule amount of fluid that is approximately 10 microliters thick can be found between the 2 layers.<xref ref-type="bibr" rid="article-26803.r3">[3]</xref>The amount of fluid in the pleural cavity is regulated by a fine balance in the oncotic and hydrostatic pressures between the pleural space and the intravascular components coupled with the perilymphatic drainage. The Frank-Starling law controls this process.<xref ref-type="bibr" rid="article-26803.r4">[4]</xref><xref ref-type="bibr" rid="article-26803.r5">[5]</xref><xref ref-type="bibr" rid="article-26803.r6">[6]</xref><xref ref-type="bibr" rid="article-26803.r5">[5]</xref><xref ref-type="bibr" rid="article-26803.r6">[6]</xref><xref ref-type="bibr" rid="article-26803.r5">[5]</xref></p>
        <p>Up to 15 percent of patients with lung cancer develop malignant pleural effusions (MPEs). However, MPEs are not limited to lung cancers and might be a clinical presentation of either adjacent or metastatic carcinomas. Accordingly, MPEs can complicate malignant mesothelioma or might be present in metastatic cancers, including lung or distant sites such as breast or ovary), lymphoma, and hematologic malignancies. Generally, the presence of an MPE implies a poor prognosis.<xref ref-type="bibr" rid="article-26803.r7">[7]</xref><xref ref-type="bibr" rid="article-26803.r8">[8]</xref><xref ref-type="bibr" rid="article-26803.r7">[7]</xref></p>
        <p>In MPEs, cancer cells infiltrate into pleural tissue. Therefore, pleural tissue invasion by malignant cells is evident on pleural biopsy, and positive fluid cytology is predicted.<xref ref-type="bibr" rid="article-26803.r9">[9]</xref></p>
        <p>Specific malignancies, including small blue-round cell tumors, including rhabdomyosarcoma in the pediatric population, have the propensity for pleural metastasis and malignant pleural effusion.<xref ref-type="bibr" rid="article-26803.r8">[8]</xref></p>
      </sec>
      <sec id="article-26803.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>&#x000a0;The third leading etiology of pleural effusion in the pediatric population is malignancy. Malignant pleural effusion develops as a result of the following:<xref ref-type="bibr" rid="article-26803.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Direct invasion of the pleural wall</p>
          </list-item>
          <list-item>
            <p>Impairment of lymphatic drainage from the pleural cavity</p>
          </list-item>
          <list-item>
            <p>Obstruction of the bronchial tree with the development of bronchial obstruction and atelectasis<xref ref-type="bibr" rid="article-26803.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>Pleural effusion secondary to malignancy can be unilateral or bilateral.<xref ref-type="bibr" rid="article-26803.r12">[12]</xref></p>
        <p>
<italic toggle="yes">
<bold>Pleural Effusion Secondary to Malignant Tumor</bold>
</italic>
</p>
        <p>Malignancy&#x000a0;as a cause of pleural effusion in children can be primary&#x000a0;malignancy or metastatic malignancy.</p>
        <p>
<italic toggle="yes">Lymphoma</italic>
</p>
        <p>Lymphoma is the most common malignancy associated with pleural effusion. About 13 % of all childhood malignancy is attributable to lymphoma. Lymphoma is also the most common cause of anterior mediastinal mass in children. Approximately 60% of lymphomas&#x000a0;are non-Hodgkin lymphoma, while the remaining 40% are Hodgkin lymphoma. Patients with lymphoma will usually present with an anterior mediastinal mass. About 5% of patients with Hodgkin or non-Hodgkin lymphoma will develop pleural effusion.<xref ref-type="bibr" rid="article-26803.r13">[13]</xref></p>
        <p>
<italic toggle="yes">Leukemia</italic>
</p>
        <p>T-cell lymphoblastic leukemia can also cause a malignant pleural effusion. In 50% to 70% of lymphoblastic leukemia, pleural effusion will develop. Bone marrow biopsy is necessary to differentiate between the 2 types of malignancy.<xref ref-type="bibr" rid="article-26803.r14">[14]</xref></p>
        <p>
<italic toggle="yes">Germ Cell Tumor (GCT)</italic>
</p>
        <p>GCT accounts for about 6% to 18% of mediastinal masses. Close to 20% of GCT are malignant. They include seminomas and non-seminomatous tumor-like teratocarcinoma, embryonal carcinoma, choriocarcinoma, yolk sac tumor, and mixed types. Encroachment into adjacent structures in the mediastinum can cause respiratory symptoms. Compression of the tracheobronchial tree and obstruction of lymphatic flow by these tumors can result in the development of pleural effusion.<xref ref-type="bibr" rid="article-26803.r15">[15]</xref><xref ref-type="bibr" rid="article-26803.r16">[16]</xref><xref ref-type="bibr" rid="article-26803.r15">[15]</xref></p>
        <p>
<italic toggle="yes">Neurogenic tumor</italic>
</p>
        <p>Neuroblastoma and ganglioneuroma make up about 90% of the posterior mediastinal mass. Growth and expansion can cause mass effect, respiratory distress, and cord compression. Neurogenic tumors generally do not cause pleural effusion.<xref ref-type="bibr" rid="article-26803.r17">[17]</xref></p>
        <p>
<italic toggle="yes">Chest wall and pulmonary malignancy</italic>
</p>
        <p>These tumors can be primary and metastatic, but it is very difficult to differentiate between the 2. Examples are carcinoids tumor, pleuropulmonary blastoma, and Askin tumors.<xref ref-type="bibr" rid="article-26803.r18">[18]</xref></p>
        <p>
<italic toggle="yes">Carcinoid tumor&#x000a0;</italic>
</p>
        <p>This type of malignancy is common in older children and adolescents. Reportedly it accounts for about 80% to 85% of primary malignant tumors in children. They can cause compressive atelectasis and pneumonia that can lead to the development of an effusion.</p>
        <p>
<italic toggle="yes">Pleuropulmonary blastoma</italic>
</p>
        <p>This is a rare tumor in pediatrics.&#x000a0;It is an embryonal, mesenchymal tumor originating from the lung and pleural cavity. Diagnosis of this malignancy is often late. Three types are histologically recognized.</p>
        <list list-type="bullet">
          <list-item>
            <p>Macro cystic</p>
          </list-item>
          <list-item>
            <p>Mixed cystic</p>
          </list-item>
          <list-item>
            <p>Solid<xref ref-type="bibr" rid="article-26803.r19">[19]</xref></p>
          </list-item>
        </list>
        <p>This tumor can invade adjacent structures causing pneumonia, spontaneous pneumothorax, and effusion.</p>
        <p>
<italic toggle="yes">Askin tumor</italic>
</p>
        <p>This is a rare form of Ewing Sarcoma or primitive neuroectodermal tumor that can arise from the bones of the rib or chest wall, or lungs. Prognosis is poor in patients with Askin tumors. The tumor can invade adjacent structures like muscle ribs, pleura, and the lungs. It can cause mass effects, with compression of nearby organs and the development of pleural effusion.<xref ref-type="bibr" rid="article-26803.r20">[20]</xref></p>
      </sec>
      <sec id="article-26803.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Three&#x000a0;main conditions cause pleural effusion in children:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection (50% to 70%)</p>
          </list-item>
          <list-item>
            <p>Congestive heart failure (5% to 15%)</p>
          </list-item>
          <list-item>
            <p>Malignancy (10% to 15%)</p>
          </list-item>
        </list>
        <p>Malignancy is a rare cause of pleural effusion in children. Non-Hodgkin lymphoma is the most common cause of MPE in children.<xref ref-type="bibr" rid="article-26803.r21">[21]</xref><xref ref-type="bibr" rid="article-26803.r22">[22]</xref><xref ref-type="bibr" rid="article-26803.r23">[23]</xref><xref ref-type="bibr" rid="article-26803.r24">[24]</xref></p>
      </sec>
      <sec id="article-26803.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The visceral pleura receives its blood supply from bronchial circulation, while the parietal pleura receives its supplies from the intercostal arteries, making the 2 layers 2 distinct anatomic structures. The visceral part of the pleura&#x000a0;does not have any sensory nerves; on the contrary,&#x000a0; the parietal part of the pleura has a rich network of sensory nerves making it very sensitive to painful stimuli. The pleural cavity aids in the mechanics of inspiration and expiration during breathing. Kampmeier's foci are a collection of lymphoreticular and mesothelial cells that acts as a &#x0201c;guard&#x0201d; by preventing the entry of undesirable substances from the pleural cavity into the media in the chest wall and mediastinum.<xref ref-type="bibr" rid="article-26803.r25">[25]</xref></p>
        <p>The pleural cavity also contains cells, some macrophages, red blood cells, and lymphocytes. The number of fluids and cells in the pleural space can change considerably in pathologic conditions.<xref ref-type="bibr" rid="article-26803.r26">[26]</xref></p>
        <p>Malignant pleural effusion occurs due to disrupted homeostatic forces that control the flow and fluid in and out of the pleural cavity. The pressure in the pleural cavity is determined by the opposing forces of the elastic recoil of the lung and the pressure from the chest wall. The pleural fluid is not in a state of hydrostatic equilibrium. This is because the vertical gradient of the pleural fluid pressure is not equal to the hydrostatic pressure. This helps to create a movement of fluids in the pleural cavity. Pulmonary and cardiac mechanics also controls the net movement of fluid in the pleural cavity. The fluid in the pleural cavity is ultrafiltrate from parietal pleura capillaries. The amount of fluid in the pleural cavity is regulated by a filtration rate that is matched by fluid outflow via the lymphatic stomata.</p>
        <p>For the development of pleural effusion in malignancy, there must be:</p>
        <list list-type="bullet">
          <list-item>
            <p>An increase in the production of pleural fluid secondary to increased hydrostatic pressure</p>
          </list-item>
          <list-item>
            <p>Decreased oncotic pressure or pleural pressure</p>
          </list-item>
          <list-item>
            <p>Increased the permeability of the microvasculature<xref ref-type="bibr" rid="article-26803.r27">[27]</xref></p>
          </list-item>
        </list>
        <p>The increased pleural fluid production must be such that the lymphatic clearance is impeded by decreased hydrostatic pressure or blockage of lymphatic drainage.</p>
        <p>The major contributing factors in the malignant pleural effusion formation are angiogenesis and vascular remodeling.<xref ref-type="bibr" rid="article-26803.r28">[28]</xref>&#x000a0;Consequent immune response within the malignant pleural effusion would alter the angiogenesis and vascular remodeling pathways.<xref ref-type="bibr" rid="article-26803.r29">[29]</xref></p>
        <p>Several in vivo studies report a&#x000a0;potential association between the infiltration of macrophages and MPE development.<xref ref-type="bibr" rid="article-26803.r30">[30]</xref>&#x000a0;The infiltered&#x000a0;M&#x003d5;s in MPE secretes transforming growth factor&#x02013;&#x003b2; (TGF-&#x003b2;) that eventually favors Foxp3&#x000a0;(forkhead box P3) regulatory T cells (Foxp3&#x000a0;T). Consequently, reduced T cell cytotoxicity is predicted. Collectively, the activated cascade results in&#x000a0;tumor progression in MPE. The infiltered M&#x003d5;s are characterized by significantly higher levels of interleukin-10 (IL-10) mRNA.<xref ref-type="bibr" rid="article-26803.r31">[31]</xref></p>
        <p>Accordingly, the IL-10, released upon&#x000a0;phagocytosis of the apoptotic cell, is considered a valid diagnostic marker for MPE.<xref ref-type="bibr" rid="article-26803.r29">[29]</xref></p>
        <p>PEs osmolality depends on the underlying pathology and is affected by the PE pH and glucose. Hypo-osmotic PEs results in decreased pleural permeability.<xref ref-type="bibr" rid="article-26803.r6">[6]</xref></p>
      </sec>
      <sec id="article-26803.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Small round cell tumors, including Ewing and rhabdomyosarcoma, are the most common malignancies involving pediatric body fluids and serosal surface involvement. The nonspecific morphology is identical. Notwithstanding the significance of immunocytochemistry in the correct diagnosis, other ancillary evaluations, specifically in hematologic malignancies and equivocal cases are recommended.<xref ref-type="bibr" rid="article-26803.r22">[22]</xref></p>
      </sec>
      <sec id="article-26803.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history and physical examination can help diagnose malignant pleural effusion. In history, attention should be focused on the chief complaint.</p>
        <p>
<bold>Chief Complaint</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Weakness</p>
          </list-item>
          <list-item>
            <p>Malaise</p>
          </list-item>
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Weight loss</p>
          </list-item>
          <list-item>
            <p>Dyspnea</p>
          </list-item>
          <list-item>
            <p>Chest pain<xref ref-type="bibr" rid="article-26803.r32">[32]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Physical Signs </bold>
</p>
        <p>Other physical signs of malignancy-induced pleural effusions are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Tachycardia</p>
          </list-item>
          <list-item>
            <p>Diaphoresis</p>
          </list-item>
          <list-item>
            <p>Neck mass</p>
          </list-item>
          <list-item>
            <p>Chest mass<xref ref-type="bibr" rid="article-26803.r33">[33]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>Patients should be examined in a position of comfort. Most patients with malignant pleural effusion usually have a mass in the mediastinal cavity that may cause respiratory distress or discomfort. The general appearance of a child with malignant pleural effusion may reveal a diaphoretic, dyspneic patient with mild to moderate respiratory distress.</p>
        <p>Auscultation might reveal a pleuritic chest rub in the early stage, which might gradually disappear as the accumulation of pleural fluid increases. Excessive fluid accumulation might cause displacement of the cardiac apex and the trachea to the contralateral side.</p>
        <p>Examination of the affected side might show dullness to percussion with decreased tactile fremitus and egophony. This might be a diagnostic challenge in an uncooperative child.</p>
      </sec>
      <sec id="article-26803.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of patients with malignant pleural effusion (MPE) starts with a detailed history, physical examination, and ancillary studies. Eliciting the time of the onset of the symptoms is important. Family history of malignancy might also help in the diagnostic work.</p>
        <p>
<bold>Ancillary Studies</bold>
</p>
        <p>
<bold>
<italic toggle="yes">Chest X-ray</italic>
</bold>
</p>
        <p>In most cases, a chest x-ray can help to confirm the size and location of the pleural effusion. It might not be able to delineate a small effusion. A&#x000a0;chest x-ray&#x000a0;might also show lobulated pleural thickening, atelectasis, consolidation, and mediastinal widening. These radiological findings are highly suggestive of malignancy.<xref ref-type="bibr" rid="article-26803.r34">[34]</xref></p>
        <p>
<bold>
<italic toggle="yes">Chest Ultrasonography</italic>
</bold>
</p>
        <p>This has close to 100% sensitivity in the detection of pleural effusion. The presence of pleural wall thickening of more than 10 mm, nodularity, and diaphragmatic wall thickening of greater than 7 mm has high specificity in diagnosing MPE.<xref ref-type="bibr" rid="article-26803.r35">[35]</xref></p>
        <p>
<bold>
<italic toggle="yes">CAT Scan</italic>
</bold>
</p>
        <p>CAT scan is a useful imaging study for MPE. It can determine the size, location, and extent of the effusion. CAT scan can also help identify the primary or metastatic tumor causing the effusion. It is superior in imaging quality to chest x-ray and chest ultrasonography.<xref ref-type="bibr" rid="article-26803.r36">[36]</xref></p>
        <p>
<bold>
<italic toggle="yes">MRI</italic>
</bold>
</p>
        <p>MRI has a limited role in the diagnostic imaging studies for pleural effusion, probably because of poor spatial resolution.<xref ref-type="bibr" rid="article-26803.r37">[37]</xref></p>
        <p>
<bold>
<italic toggle="yes">Pleural Thoracentesis</italic>
</bold>
</p>
        <p>This is a useful test that can serve both diagnostic and therapeutic purposes. If the drainage is hemorrhagic or exudative, a high index of suspicion should be entertained for malignancy. The pleural fluid should be analyzed for the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>pH<xref ref-type="bibr" rid="article-26803.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>Protein<xref ref-type="bibr" rid="article-26803.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Glucose<xref ref-type="bibr" rid="article-26803.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Lactate dehydrogenase<xref ref-type="bibr" rid="article-26803.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Red blood cells</p>
          </list-item>
          <list-item>
            <p>White blood cells</p>
          </list-item>
          <list-item>
            <p>Neutrophils</p>
          </list-item>
          <list-item>
            <p>Basophils<xref ref-type="bibr" rid="article-26803.r41">[41]</xref></p>
          </list-item>
          <list-item>
            <p>Eosinophils<xref ref-type="bibr" rid="article-26803.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>pleural fluid adenosine deaminase (pADA) and pleural fluid carcinoembryonic antigen (pCEA)<xref ref-type="bibr" rid="article-26803.r43">[43]</xref></p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Cytology</italic>
</bold>
</p>
        <p>In about 50% of cases, malignant cells might be detected in pleural fluids. The diagnostic yield is about 40% to 87%.</p>
        <p>Using Lights criteria for pleural fluids, MPE is usually an exudate. In some rare cases, MPE might present as a transudate. In MPE, a parapneumonic effusion might develop, and the pleural fluid pH is usually below 7.3 with glucose levels less than 60 mg/dl.<xref ref-type="bibr" rid="article-26803.r44">[44]</xref></p>
        <p>
<bold>
<italic toggle="yes">Lights Criteria</italic>
</bold>
</p>
        <p>Lights criteria for exudative pleural fluid:</p>
        <list list-type="bullet">
          <list-item>
            <p>A ratio of the pleural protein to serum protein that is more than 0.5</p>
          </list-item>
          <list-item>
            <p>A ratio of the pleural lactate dehydrogenase (LDH) to serum LDH that is&#x000a0;more than 0.6</p>
          </list-item>
          <list-item>
            <p>LDH of the pleural fluid that is&#x000a0;more &#x000a0;than two-thirds the upper limit of serum LDH<xref ref-type="bibr" rid="article-26803.r45">[45]</xref><xref ref-type="bibr" rid="article-26803.r46">[46]</xref></p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Exudative Pleural Effusion</italic>
</bold>
</p>
        <p>Common causes&#x000a0;are malignancy, parapneumonic effusion, and tuberculosis.</p>
        <p>
<bold>
<italic toggle="yes">Transudative Pleural Effusion</italic>
</bold>
</p>
        <p>Common causes&#x000a0;are left ventricular failure, liver cirrhosis, and nephrotic syndrome.</p>
        <p>
<bold>
<italic toggle="yes">Pleural Fluid Cytology</italic>
</bold>
</p>
        <p>The diagnostic yield of cytology is dependent on several factors.</p>
        <list list-type="bullet">
          <list-item>
            <p>Number of specimens taken</p>
          </list-item>
          <list-item>
            <p>Type of fixative solutions</p>
          </list-item>
          <list-item>
            <p>Time for specimen transportation</p>
          </list-item>
          <list-item>
            <p>Expertise of cytopathologist</p>
          </list-item>
          <list-item>
            <p>Histopathology of the specimen</p>
          </list-item>
          <list-item>
            <p>Nature and type of primary malignancy</p>
          </list-item>
          <list-item>
            <p>Extent of disease</p>
          </list-item>
          <list-item>
            <p>The use of cell blocks<xref ref-type="bibr" rid="article-26803.r47">[47]</xref><xref ref-type="bibr" rid="article-26803.r48">[48]</xref><xref ref-type="bibr" rid="article-26803.r49">[49]</xref><xref ref-type="bibr" rid="article-26803.r48">[48]</xref></p>
          </list-item>
        </list>
        <p>The pleural fluid can also be analyzed for tumor markers. This is more commonly done in adults with pulmonary, breast, colon, ovary, and prostate cancer. Tumor markers are substances with a high molecular mass presence which in the pleural fluid is associated with primary or metastatic malignancy. Tumor markers are useful as:</p>
        <list list-type="bullet">
          <list-item>
            <p>An adjunct in clinical diagnosis</p>
          </list-item>
          <list-item>
            <p>Identification of metastases in the pleural cavity</p>
          </list-item>
          <list-item>
            <p>Identification of the malignancy's primary origin</p>
          </list-item>
        </list>
        <p>
<bold>Common Tumor Markers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Carcinoembryonic antigen (CEA)<xref ref-type="bibr" rid="article-26803.r41">[41]</xref></p>
          </list-item>
          <list-item>
            <p>Cancer antigens 15-3 (CA 15-3)<xref ref-type="bibr" rid="article-26803.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p>CA 72-4<xref ref-type="bibr" rid="article-26803.r51">[51]</xref></p>
          </list-item>
          <list-item>
            <p>CA 125<xref ref-type="bibr" rid="article-26803.r52">[52]</xref></p>
          </list-item>
          <list-item>
            <p>Carbohydrate antigen 19-9 (CA 19-9)<xref ref-type="bibr" rid="article-26803.r53">[53]</xref></p>
          </list-item>
          <list-item>
            <p>Cyfra 21-1<xref ref-type="bibr" rid="article-26803.r54">[54]</xref></p>
          </list-item>
          <list-item>
            <p>Cytokeratin fragment-21-1<xref ref-type="bibr" rid="article-26803.r55">[55]</xref></p>
          </list-item>
          <list-item>
            <p>Stage-specific embryonic antigen-1<xref ref-type="bibr" rid="article-26803.r56">[56]</xref></p>
          </list-item>
          <list-item>
            <p>Nonspecific enolase</p>
          </list-item>
        </list>
        <p>
<bold>Pleural Biopsy</bold>
</p>
        <p>This can be considered a diagnostic tool. Needle biopsy of pleural tissue combined with fluid cytology of MPE can aid in diagnosis. The&#x000a0;procedure can be done under local or general anesthesia.</p>
        <p>
<bold>Thoracoscopy</bold>
</p>
        <p>Thoracoscopy or pleuroscopy can be done using video-assisted thoracoscopy. The technique is relatively simple, and the procedure can be done under local or general anesthesia. Under local anesthesia, the procedure can be done with a semi-rigid or rigid thoracoscope.<xref ref-type="bibr" rid="article-26803.r57">[57]</xref></p>
        <p>The diagnostic yield is around 95% to 97%. Endoscopy findings suggest malignancy are pleural ulceration, multiple nodules, and polypoidal masses.</p>
        <p>
<bold>Bronchoscopy</bold>
</p>
        <p>This method is indicated in a patient with MPE with hemoptysis or suspicion of the primary tumor originating from the bronchopulmonary tree.<xref ref-type="bibr" rid="article-26803.r45">[45]</xref></p>
      </sec>
      <sec id="article-26803.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Managing malignant pleural effusion requires a multidisciplinary approach with coordinated care between a pediatric hematologist-oncologist, a pediatric surgeon, and an interventional radiologist. The most common cause of MPE in a pediatric population is non-Hodgkin lymphoma. The initial chemotherapy treatment should be directed towards the primary cause of the effusion.<xref ref-type="bibr" rid="article-26803.r58">[58]</xref><xref ref-type="bibr" rid="article-26803.r59">[59]</xref><xref ref-type="bibr" rid="article-26803.r60">[60]</xref><xref ref-type="bibr" rid="article-26803.r61">[61]</xref></p>
        <p>Thoracocentesis</p>
        <p>The main goals of thoracentesis are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Removal of the pleural effusion</p>
          </list-item>
          <list-item>
            <p>Clinical improvement in symptoms</p>
          </list-item>
          <list-item>
            <p>The prevention of&#x000a0; fluid re-accumulation<xref ref-type="bibr" rid="article-26803.r62">[62]</xref></p>
          </list-item>
        </list>
        <p>Thoracentesis for MPE is for both diagnostic and therapeutic purposes. Most patients with MFE will have a mass in the thoracic cavity causing respiratory compromise and difficulty breathing. Mild effusion can be monitored with serial x-ray and chest ultrasound while the patient is undergoing chemotherapy. For moderate to large effusion, thoracentesis using the Seldinger technique can be utilized. For patients with large pleural effusion, it is better to remove the fluid slowly, as aggressive removal of pleural fluid might lead to re-expansion of pulmonary edema, which can also compromise the respiratory status of the patient.</p>
        <p>In the absence of immediate improvement following the thoracentesis, alternative causes of symptoms, including non-expandable lungs, severe cardiopulmonary failure, and lymphangitic cancer, should be considered. However, in terms of immediate symptoms improvement, patients should still be monitored for the clinical recurrence of dyspnea and chest pain. The presence of any evidence of sign and or symptom recurrence dictates the follow-up with chest x-ray, chest CT or chest ultrasound. The recurrence of pleural effusion should be differentiated from the alternative causalities, including but not limited to the non-expandable lungs and severe cardiopulmonary failure.</p>
        <p>If the recurrence is acute within the first month following the thoracentesis, the patient should be evaluated for intra-pleural catheter placement and drainage. Intrapleural catheter placement is generally recommended in these circumstances and has several advantages, including;1.&#x000a0;a minimally invasive procedure, 2. it offers spontaneous pleurodesis, and 3. IPC can be performed in an outpatient setting along with pleurodesis.<xref ref-type="bibr" rid="article-26803.r63">[63]</xref></p>
        <p>
<bold>Tube Thoracostomy</bold>
<bold/>
</p>
        <p>For patients with a short life expectancy and recurrent MFE&#x000a0;or very young patients under moderate anesthesia, a tube thoracostomy can be performed under local anesthesia. A 7 to 16 Fr chest tube can be utilized for drainage. The tube is usually inserted in the fourth or fifth intercostal space along the anterior or middle auxiliary line. The tube should not be in place for too long because of the risk of infection, bleeding, or pneumothorax.</p>
        <p>Chest tube or small-bore catheter drainage is considered an alternative to large volume thoracentesis. Chest tube drainage might be specifically performed in patients with large fluid volumes. A consistent and slow rate of pleural fluid removal might be planned for this group of patients.<xref ref-type="bibr" rid="article-26803.r64">[64]</xref></p>
        <p>
<bold>Pleurodesis</bold>
</p>
        <p>After the evacuation of MFE, the next step, depending on the life expectancy of the patient, is pleurodesis. Pleurodesis is the obliteration of the pleural space with the sole purpose of preventing reaccumulation of pleural fluid. This is for patients who are expected to survive for more than 3 months.<xref ref-type="bibr" rid="article-26803.r64">[64]</xref></p>
        <p>Several agents can be used for pleurodesis.</p>
        <p>
<bold>
<italic toggle="yes">Chemical Pleurodesis</italic>
</bold>
</p>
        <p>Agents for chemical pleurodesis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bleomycin</p>
          </list-item>
          <list-item>
            <p>Tetracycline/doxycycline</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Corynebacterium parvum</italic> extract</p>
          </list-item>
          <list-item>
            <p>Silver nitrate</p>
          </list-item>
          <list-item>
            <p>Iodopovidone, quinacrine</p>
          </list-item>
          <list-item>
            <p>Interferons</p>
          </list-item>
          <list-item>
            <p>Interleukin-2<xref ref-type="bibr" rid="article-26803.r65">[65]</xref></p>
          </list-item>
        </list>
        <p>Bleomycin as an agent for pleurodesis has a relatively high success rate in adults, close to 60% to 80%.</p>
        <p>
<bold>
<italic toggle="yes">Talc</italic>
</bold>
</p>
        <p>Talc is also another effective substance that is widely used for pleurodesis. It can be applied as a powder or slurry. As a powder, talc is introduced into the pleural cavity in the form of powder to irritate to opposing surface and seal the pleural cavity. A slurry combines talc in 5% dextrose and a local anesthetic agent that can be instilled into the pleural cavity as a sealant.</p>
        <p>The procedure can be done conventionally or with video-assisted thoracoscopy (VAT).</p>
        <p>
<bold>Tunneled&#x000a0;Indwelling Pleural Catheter</bold>
</p>
        <p>For a palliative purpose, patients with recurrent MFE can have a tunneled indwelling pleural catheter inserted under local anesthesia or moderate sedation. Intermittent catheter drainage can be done by a family member or qualified healthcare professional.<xref ref-type="bibr" rid="article-26803.r66">[66]</xref></p>
        <p>
<bold>Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Hemothorax</p>
          </list-item>
          <list-item>
            <p>Empyema</p>
          </list-item>
          <list-item>
            <p>Obstruction with the development of tension pleural effusion</p>
          </list-item>
        </list>
        <p>This palliative treatment method has become popular as patients can be managed&#x000a0;in an outpatient setting. Consequently, costs are less due to shorter hospitalization and reduced recovery time.</p>
        <p>
<bold>Pleuroperitoneal Shunt</bold>
</p>
        <p>This is a palliative measure that can be used for patients who are not candidates for pleurodesis. The procedure creates a chronic drainage system that connects the pleural and peritoneal cavity. It is rarely used in the pediatric population and only as a palliative measure in adults.</p>
        <p>In summary:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Thoracentesis:</italic>&#x000a0;Repeated aspiration of MPE is indicated for patients with a limited lifespan and is justified to provide symptomatic relief</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Thoracostomy:</italic>&#x000a0; Indicated if survival is about a month or more to justify the risk and or benefit of thoracostomy</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Pleurodesis:</italic>&#x000a0;Indicated if survival is more tthan2 to 3 months.<xref ref-type="bibr" rid="article-26803.r67">[67]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26803.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of malignant pleural effusion should include other causes of pleural effusion. In pediatrics, the most common cause of the pleural effusion is an infection. This is usually pneumonia with parapneumonic effusion. The causative organism for pneumonia and other infectious causes of pleural effusion has been discussed earlier. Pleural effusion from congestive heart failure&#x000a0;should also be considered as fluid can accumulate in the pleural cavity from heart failure. Most of the heart failure in the&#x000a0;pediatric population is from congenital heart diseases.<xref ref-type="bibr" rid="article-26803.r68">[68]</xref></p>
        <p>Chylothorax can develop in pediatric patients with congenital heart disease after surgery. This might be due to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Injury to the thoracic duct</p>
          </list-item>
          <list-item>
            <p>Venous or lymphatic congestion</p>
          </list-item>
          <list-item>
            <p>Central venous thrombosis<xref ref-type="bibr" rid="article-26803.r69">[69]</xref></p>
          </list-item>
        </list>
        <p>In any case, the chylous fluid with a milky white appearance can accumulate in the pleural fluid and cause significant effusion with respiratory compromise.</p>
        <p>In the differential diagnosis, a detailed history and physical examination can help the clinician. Ancillary studies can assist with the history and physical examination. Thoracentesis with the pleural fluid analysis is especially useful.&#x000a0;The Lights criteria can differentiate between exudate and transudate. The glucose level in the pleural fluid is similar to the level in the plasma. In MPE, the pleural fluid glucose level is usually lower than 60 mg/dl. The pH of the pleural fluid is usually lower than 7.3 in MPE. Pleural effusion secondary to infection is exudative in nature, while effusion from heart failure is transudative. In MPE, it is sometimes very difficult to distinguish between the 2 types of effusion. However, in nearly 95% of the MPE cases, the pleural fluid is exudative. Analysis of pleural fluid for malignant cells can sometimes be helpful, albeit with false positive results. In adults, the pleural fluid might be sent for tumor markers to help identify the primary tumor causing the effusion.<xref ref-type="bibr" rid="article-26803.r70">[70]</xref></p>
      </sec>
      <sec id="article-26803.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of MPE depends on the primary tumor causing the effusion.<xref ref-type="bibr" rid="article-26803.r8">[8]</xref><xref ref-type="bibr" rid="article-26803.r71">[71]</xref>&#x000a0;Neuroblastoma and rhabdomyosarcoma are the most common pediatric malignancies with a propensity for malignant pleural effusion. The survival rate in patients with multiple episodes of malignant pleural effusion is remarkably affected, and poor outcomes are predicted.<xref ref-type="bibr" rid="article-26803.r71">[71]</xref></p>
      </sec>
      <sec id="article-26803.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complications from MPE are respiratory distress and respiratory failure.</p>
        <p>The risk of respiratory failure or cardiovascular collapse is high if MPE is caused by a mediastinal mass compressing the trachea and other vital organs in the mediastinum.</p>
      </sec>
      <sec id="article-26803.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Management of MPE requires coordination of care between several subspecialties. The hematologist-oncologist is primarily responsible for the care of the patient and is responsible for the establishment of the initial diagnosis of the tumor. This might be a primary or metastatic that is causing the development of pleural effusion. The hematologist-oncologist initiates chemotherapy and/or radiation therapy. Management of the malignant pleural effusion usually has several options depending on the size, type, and location of the effusion. Thoracentesis, thoracotomy, pleurodesis, and placement of a pleuroperitoneal shunt are the treatment options utilized for MFE. This requires the involvement of either a pediatric surgeon, cardiothoracic surgeon, or interventional radiologist.</p>
        <p>Palliative care and rehabilitation are also part of the treatment plan for patients with MPE.</p>
      </sec>
      <sec id="article-26803.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of malignant pleural effusion required an interprofessional approach with coordinated care between pediatric hematologist-oncologist, a pediatric surgeon, and interventional radiologist. The most common cause of MPE in a pediatric population is non-Hodgkin lymphoma. The initial treatment which is chemotherapy should be directed towards the primary cause of the effusion.&#x000a0;<xref ref-type="bibr" rid="article-26803.r72">[72]</xref><xref ref-type="bibr" rid="article-26803.r73">[73]</xref></p>
        <p>The management of the malignant pleural effusion usually has several options depending on the size, type, and location of the effusion. Thoracentesis, thoracotomy, pleurodesis, and placement of a pleuroperitoneal shunt are the treatment options utilized for MFE. This requires the involvement of either a pediatric surgeon, cardiothoracic surgeon, or interventional radiologist.</p>
        <p>Palliative care and rehabilitation is also part of the treatment plan for patients with MFE. A pain specialist, oncology nurse and social work must be involved in the care of these patients.</p>
      </sec>
      <sec id="article-26803.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26803&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26803">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/pediatric-malignant-pleural-effusion/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26803">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26803/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26803">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26803.s16">
        <title>References</title>
        <ref id="article-26803.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yalcin</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Choong</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Eizenberg</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Anatomy and pathophysiology of the pleura and pleural space.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10, v</page-range>
            <pub-id pub-id-type="pmid">23206712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasyukov</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Kagan</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Tretyakov</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>[Anatomometric characteristics and pleural cavity changes after pneumonectomy].</article-title>
            <source>Khirurgiia (Mosk)</source>
            <year>2021</year>
            <issue>5</issue>
            <fpage>32</fpage>
            <page-range>32-41</page-range>
            <pub-id pub-id-type="pmid">33977696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r3">
          <label>3</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Krishna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Antoine</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Alahmadi</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Rudrappa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Pleural Effusion</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">28846252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charalampidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Youroukou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lazaridis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mpoukovinas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Karavasilis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kioumis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pitsiou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papaiwannou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karavergou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sarika</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kapanidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakkas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Korantzis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lampaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Physiology of the pleural space.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>Suppl 1</issue>
            <fpage>S33</fpage>
            <page-range>S33-7</page-range>
            <pub-id pub-id-type="pmid">25774305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charalampidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Youroukou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lazaridis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mpoukovinas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Karavasilis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kioumis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pitsiou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papaiwannou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karavergou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sarika</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kapanidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakkas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Korantzis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lampaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pleura space anatomy.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>Suppl 1</issue>
            <fpage>S27</fpage>
            <page-range>S27-32</page-range>
            <pub-id pub-id-type="pmid">25774304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peppa</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Solenov</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Kalomenidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tsilioni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gourgoulianis</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Hatzoglou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zarogiannis</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusion osmolality correlation with pH and glucose level of pleural fluid and its effects on the pleural membrane permeability.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>285</volume>
            <fpage>103581</fpage>
            <pub-id pub-id-type="pmid">33189926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asciak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kanellakis</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Abd Hamid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bedawi</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fsadni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Montefort</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.</article-title>
            <source>Front Oncol</source>
            <year>2021</year>
            <volume>11</volume>
            <fpage>658395</fpage>
            <pub-id pub-id-type="pmid">33996582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Carlo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toffolutti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Milano</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Manzitti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruggiero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dall'Igna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Melchionda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zanetti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scarzello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bisogno</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>11</issue>
            <fpage>e27932</fpage>
            <pub-id pub-id-type="pmid">31385434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dipper</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Preston</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Interventions for the management of malignant pleural effusions: a network meta-analysis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2020</year>
            <month>Apr</month>
            <day>21</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD010529</fpage>
            <pub-id pub-id-type="pmid">32315458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestation of pediatric mediastinal tumors, a single center experience.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>98</volume>
            <issue>32</issue>
            <fpage>e16732</fpage>
            <pub-id pub-id-type="pmid">31393382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jany</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2019</year>
            <month>May</month>
            <day>24</day>
            <volume>116</volume>
            <issue>21</issue>
            <fpage>377</fpage>
            <page-range>377-386</page-range>
            <pub-id pub-id-type="pmid">31315808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asciak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kanellakis</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Bibby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gerry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Fsadni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Montefort</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.</article-title>
            <source>Chest</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>5</issue>
            <fpage>1925</fpage>
            <page-range>1925-1933</page-range>
            <pub-id pub-id-type="pmid">34119515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCarten</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Shulkin</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.</article-title>
            <source>Pediatr Radiol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>11</issue>
            <fpage>1545</fpage>
            <page-range>1545-1564</page-range>
            <pub-id pub-id-type="pmid">31620854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kashif</surname>
                <given-names>RU</given-names>
              </name>
              <name>
                <surname>Faizan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anwar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Malignant Mediastinal Masses.</article-title>
            <source>J Coll Physicians Surg Pak</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>258</fpage>
            <page-range>258-262</page-range>
            <pub-id pub-id-type="pmid">30823954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paradies</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zullino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Orofino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leggio</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mediastinal teratomas in children. Case reports and review of the literature.</article-title>
            <source>Ann Ital Chir</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>395</fpage>
            <page-range>395-403</page-range>
            <pub-id pub-id-type="pmid">23685310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viet</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Khuyen</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>DQ</given-names>
              </name>
              <name>
                <surname>Chien</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Duc</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Anh</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Hai</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Ngoc</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Duc</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Coincidence of juvenile granulosa cell tumor and serous cystadenoma in a pediatric patient: Case report and literature review.</article-title>
            <source>Radiol Case Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>2370</fpage>
            <page-range>2370-2375</page-range>
            <pub-id pub-id-type="pmid">34306284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riccipetitoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bertozzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gazzaneo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raffaele</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vatta</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The Role of Video-Assisted Thoracoscopic Surgery in Pediatric Oncology: Single-Center Experience and Review of the Literature.</article-title>
            <source>Front Pediatr</source>
            <year>2021</year>
            <volume>9</volume>
            <fpage>721914</fpage>
            <pub-id pub-id-type="pmid">34712630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bay</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kebudi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>&#x00130;riba&#x0015f;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x000f6;rg&#x000fc;n</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>A&#x0011f;ao&#x0011f;lu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>G&#x000fc;n</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>&#x000c7;elik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Darendeliler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>RE: Osteosarcoma of the rib: a rare presentation.</article-title>
            <source>Turk Pediatri Ars</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>270</fpage>
            <pub-id pub-id-type="pmid">30872933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chadha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pleuropulmonary blastoma.</article-title>
            <source>J Indian Med Assoc</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>128</fpage>
            <page-range>128-9</page-range>
            <pub-id pub-id-type="pmid">24003574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghorfi</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Lambatten</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kettani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abid</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rapidly fatal Askin's tumor: a case report and literature review.</article-title>
            <source>Pan Afr Med J</source>
            <year>2014</year>
            <volume>18</volume>
            <fpage>104</fpage>
            <pub-id pub-id-type="pmid">25404964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baniak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Podberezin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kanthan</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Kanthan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Primary pulmonary/pleural melanoma in a 13 year-old presenting as pleural effusion.</article-title>
            <source>Pathol Res Pract</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>213</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-164</page-range>
            <pub-id pub-id-type="pmid">27894618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Andraws</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Almutairi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Saied</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Elbagir-Mohamed</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Cytologic and Immunophenotypic Features of Malignant Cells in Pediatric Body Fluids.</article-title>
            <source>Acta Cytol</source>
            <year>2015</year>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>332</fpage>
            <page-range>332-8</page-range>
            <pub-id pub-id-type="pmid">26422236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Margol</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Finlay</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Gilles</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Couch</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Asgharzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Erdreich-Epstein</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia.</article-title>
            <source>Front Oncol</source>
            <year>2015</year>
            <volume>5</volume>
            <fpage>191</fpage>
            <pub-id pub-id-type="pmid">26380221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Utine</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Oz&#x000e7;elik</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kiper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Do&#x0011f;ru</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yal&#x000e7;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cobano&#x0011f;lu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pekcan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cengiz</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Ceyhan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Se&#x000e7;meer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>G&#x000f6;&#x000e7;men</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pediatric pleural effusions: etiological evaluation in 492 patients over 29 years.</article-title>
            <source>Turk J Pediatr</source>
            <year>2009</year>
            <season>May-Jun</season>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-9</page-range>
            <pub-id pub-id-type="pmid">19817263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Popper</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Progression and metastasis of lung cancer.</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-91</page-range>
            <pub-id pub-id-type="pmid">27018053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Wit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siddiqi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tiemessen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Snabel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Veenstra</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Oosterwijk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Verhagen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Isolation of multipotent progenitor cells from pleura and pericardium for tracheal tissue engineering purposes.</article-title>
            <source>J Cell Mol Med</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>23</issue>
            <fpage>10869</fpage>
            <page-range>10869-10878</page-range>
            <pub-id pub-id-type="pmid">34725901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skok</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hladnik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crnjac</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Malignant Pleural Effusion and Its Current Management: A Review.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2019</year>
            <month>Aug</month>
            <day>15</day>
            <volume>55</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31443309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murthy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ekeke</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Luketich</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Soloff</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Dhupar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lotze</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Making cold malignant pleural effusions hot: driving novel immunotherapies.</article-title>
            <source>Oncoimmunology</source>
            <year>2019</year>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>e1554969</fpage>
            <pub-id pub-id-type="pmid">30906651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Giannou</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shiri</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Liebold</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Steglich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bedke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000fc;cke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scognamiglio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kempski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Woestemeier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agalioti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zazara</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Lindner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Janning</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hennigs</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Jagirdar</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Kotsiou</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Zarogiannis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Izbicki</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rothlin</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Bosurgi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gagliani</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Efferocytosis fuels malignant pleural effusion through TIMP1.</article-title>
            <source>Sci Adv</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>33</issue>
            <pub-id pub-id-type="pmid">34389533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Budna</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaczmarek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kolecka-Bednarczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spychalski</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Zawierucha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Go&#x0017a;dzik-Spychalska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nowicki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Batura-Gabryel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sikora</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions.</article-title>
            <source>J Immunol Res</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9876014</fpage>
            <pub-id pub-id-type="pmid">29785404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.</article-title>
            <source>Cancer Immunol Immunother</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>70</volume>
            <issue>10</issue>
            <fpage>3057</fpage>
            <page-range>3057-3059</page-range>
            <pub-id pub-id-type="pmid">34347147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Duan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>e0193714</fpage>
            <pub-id pub-id-type="pmid">29641601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Toubes</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>San Jos&#x000e9;</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez-Antelo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Golpe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Advances in pleural effusion diagnostics.</article-title>
            <source>Expert Rev Respir Med</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-66</page-range>
            <pub-id pub-id-type="pmid">31640432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reamy</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Odom</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Pleuritic Chest Pain: Sorting Through the Differential Diagnosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>306</fpage>
            <page-range>306-312</page-range>
            <pub-id pub-id-type="pmid">28925655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Chest Tube Drainage of the Pleural Space: A Concise Review for Pulmonologists.</article-title>
            <source>Tuberc Respir Dis (Seoul)</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>81</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-115</page-range>
            <pub-id pub-id-type="pmid">29372629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fjaellegaard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koefod Petersen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reuter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malene Fischer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gerke</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Frost Clementsen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laursen</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bodtger</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.</article-title>
            <source>Lung Cancer</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>162</volume>
            <fpage>106</fpage>
            <page-range>106-118</page-range>
            <pub-id pub-id-type="pmid">34775214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peng</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>XS</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>XZ</given-names>
              </name>
              <name>
                <surname>Ruan</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>[Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].</article-title>
            <source>Zhonghua Yi Xue Za Zhi</source>
            <year>2021</year>
            <month>Aug</month>
            <day>10</day>
            <volume>101</volume>
            <issue>30</issue>
            <fpage>2363</fpage>
            <page-range>2363-2369</page-range>
            <pub-id pub-id-type="pmid">34404128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crowe</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Kucera</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Soker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bellinger</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Petty</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.</article-title>
            <source>Nat Nanotechnol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-216</page-range>
            <pub-id pub-id-type="pmid">34916656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kaphle</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alraiyes</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>The pH-Glucose Relationship in Malignant Pleural Effusion.</article-title>
            <source>J Bronchology Interv Pulmonol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>e17</fpage>
            <page-range>e17-8</page-range>
            <pub-id pub-id-type="pmid">27058725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Phua</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Algoso</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Tee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Goh</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tai</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Kor</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Abisheganaden</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>26</issue>
            <fpage>e3996</fpage>
            <pub-id pub-id-type="pmid">27368006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing malignant pleural effusion using clinical and analytical parameters.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>e22689</fpage>
            <pub-id pub-id-type="pmid">30390322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A narrative review of malignant eosinophilic pleural effusion: incidence, etiology and prognostic significance.</article-title>
            <source>Ann Palliat Med</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>2314</fpage>
            <page-range>2314-2322</page-range>
            <pub-id pub-id-type="pmid">33549025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.</article-title>
            <source>J Clin Lab Anal</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">27976800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asciak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Malignant Pleural Effusion: From Diagnostics to Therapeutics.</article-title>
            <source>Clin Chest Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-193</page-range>
            <pub-id pub-id-type="pmid">29433714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saguil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wyrick</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hallgren</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic approach to pleural effusion.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Jul</month>
            <day>15</day>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-104</page-range>
            <pub-id pub-id-type="pmid">25077579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia-Reina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lacambra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lopez DE Castro</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Rosell</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Light's criteria in cytologically proved malignant pleural effusions.</article-title>
            <source>Minerva Med</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">34180643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basso</surname>
                <given-names>SMM</given-names>
              </name>
              <name>
                <surname>Lumachi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Del Conte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sulfaro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maffeis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ubiali</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Malignant Pleural Effusion Using CT Scan and Pleural-Fluid Cytology Together. A Preliminary Case-Control Study.</article-title>
            <source>Anticancer Res</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>1135</fpage>
            <page-range>1135-1139</page-range>
            <pub-id pub-id-type="pmid">32014965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.</article-title>
            <source>Am J Med Sci</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>360</volume>
            <issue>3</issue>
            <fpage>236</fpage>
            <page-range>236-242</page-range>
            <pub-id pub-id-type="pmid">32423747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rani</surname>
                <given-names>SSS</given-names>
              </name>
              <name>
                <surname>Vamshidhar</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Cell Block Technique in the Cytodiagnosis of Malignant Serous Effusions.</article-title>
            <source>Maedica (Bucur)</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-21</page-range>
            <pub-id pub-id-type="pmid">34221151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.</article-title>
            <source>Exp Ther Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>232</fpage>
            <page-range>232-238</page-range>
            <pub-id pub-id-type="pmid">25452808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).</article-title>
            <source>Comput Math Methods Med</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>1704948</fpage>
            <pub-id pub-id-type="pmid">35912162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Qama</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Pleural cancer antigen-125 levels in benign and malignant pleural effusions.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2013</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>693</fpage>
            <page-range>693-7</page-range>
            <pub-id pub-id-type="pmid">23575338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Son</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.</article-title>
            <source>Pathology</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-9</page-range>
            <pub-id pub-id-type="pmid">25551300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.</article-title>
            <source>Postgrad Med</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>644</fpage>
            <page-range>644-648</page-range>
            <pub-id pub-id-type="pmid">28506100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ikegaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaku</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirabayashi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>e0185850</fpage>
            <pub-id pub-id-type="pmid">28968445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metzemaekers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malengier-Devlies</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vandendriessche</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yserbyt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matthys</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Somer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wouters</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Proost</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Synovial Fluid Neutrophils From Patients With Juvenile Idiopathic Arthritis Display a Hyperactivated Phenotype.</article-title>
            <source>Arthritis Rheumatol</source>
            <year>2021</year>
            <month>May</month>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>875</fpage>
            <page-range>875-884</page-range>
            <pub-id pub-id-type="pmid">33264510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pleural staging using local anesthetic thoracoscopy in dry pleural dissemination and minimal pleural effusion.</article-title>
            <source>Thorac Cancer</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>1195</fpage>
            <page-range>1195-1202</page-range>
            <pub-id pub-id-type="pmid">33629523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Auger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schiff</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Outcome of indwelling tunneled PleurX&#x000ae; catheter placement in pediatric and young adult patients with malignant effusions.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>1118</fpage>
            <page-range>1118-20</page-range>
            <pub-id pub-id-type="pmid">24474328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>den Hollander</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rapoport</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zwaan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Temple</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>1007</fpage>
            <page-range>1007-12</page-range>
            <pub-id pub-id-type="pmid">24376007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trovato</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Sperandeo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Catalano</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Optimization of thoracic US guidance for lung nodule biopsy.</article-title>
            <source>Radiology</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>270</volume>
            <issue>1</issue>
            <fpage>308</fpage>
            <pub-id pub-id-type="pmid">24354382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Emil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zavalkoff</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ganey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gaudreault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mandel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perreault</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pharand</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Transitioning from stiff chest tubes to soft pleural catheters: prospective assessment of a practice change.</article-title>
            <source>Eur J Pediatr Surg</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>389</fpage>
            <page-range>389-93</page-range>
            <pub-id pub-id-type="pmid">23444073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;ldaval</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Anar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Polat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gayaf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yavuz</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Korkmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al&#x00131;c&#x00131;</surname>
                <given-names>&#x00130;O</given-names>
              </name>
              <name>
                <surname>Karadeniz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>B&#x000fc;y&#x000fc;k&#x0015f;irin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aydo&#x0011f;du</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Contribution of Cell Block Obtained by Thoracentesis in the Diagnosis of Malignant Pleural Effusion.</article-title>
            <source>J Cytol</source>
            <year>2019</year>
            <season>Oct-Dec</season>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>205</fpage>
            <page-range>205-208</page-range>
            <pub-id pub-id-type="pmid">31741579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez-Antelo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pleural procedures in the management of malignant effusions.</article-title>
            <source>Ann Thorac Med</source>
            <year>2017</year>
            <season>Jan-Mar</season>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-10</page-range>
            <pub-id pub-id-type="pmid">28197215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sheikh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Youness</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Keddissi</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Abdo</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Malignant Pleural Effusion: A Decade in Review.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2022</year>
            <month>Apr</month>
            <day>18</day>
            <volume>12</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35454064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beltsios</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Mavrovounis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adamou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Panagiotopoulos</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.</article-title>
            <source>Gen Thorac Cardiovasc Surg</source>
            <year>2021</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>832</fpage>
            <page-range>832-842</page-range>
            <pub-id pub-id-type="pmid">33222091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shawwa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alokla</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Omballi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alraiyes</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Tunneled Pleural Catheter for the Treatment of Malignant Pleural Effusion: A Systematic Review and Meta-analysis.</article-title>
            <source>Am J Ther</source>
            <year>2016</year>
            <season>Nov/Dec</season>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>e1300</fpage>
            <page-range>e1300-e1306</page-range>
            <pub-id pub-id-type="pmid">25654292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bakhos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abbas</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Management of Malignant Lung Entrapment, the Oncothorax.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-90</page-range>
            <pub-id pub-id-type="pmid">29150040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allama</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Abou-Elela</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Pleural and serum markers for diagnosis of malignant pleural effusion.</article-title>
            <source>Asian Cardiovasc Thorac Ann</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>560</fpage>
            <page-range>560-565</page-range>
            <pub-id pub-id-type="pmid">32741198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tutor</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Chylothorax in infants and children.</article-title>
            <source>Pediatrics</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>133</volume>
            <issue>4</issue>
            <fpage>722</fpage>
            <page-range>722-33</page-range>
            <pub-id pub-id-type="pmid">24685960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Modi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khurana</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Soni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chaudhary</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shet</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>10</issue>
            <fpage>E389</fpage>
            <page-range>E389-E394</page-range>
            <pub-id pub-id-type="pmid">34296830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parsons</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Jarzembowski</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathologic analysis of malignant effusions in pediatric patients.</article-title>
            <source>J Am Soc Cytopathol</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>41</fpage>
            <page-range>41-47</page-range>
            <pub-id pub-id-type="pmid">31042633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Pitlik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abdul-Karim</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary.</article-title>
            <source>Acta Cytol</source>
            <year>1997</year>
            <season>Mar-Apr</season>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>467</fpage>
            <page-range>467-73</page-range>
            <pub-id pub-id-type="pmid">9100782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26803.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anghelescu</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Burgoyne</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Pui</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Furman</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Sandlund</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses.</article-title>
            <source>Paediatr Anaesth</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>1090</fpage>
            <page-range>1090-8</page-range>
            <pub-id pub-id-type="pmid">17897276</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
